Photo: Thomas Barwick/Getty Images
Digital health company Amalgam Rx is looking to the conversational AI space with the acquisition of data science-focused startup Geetha s assets.
Geetha has developed AI models that can learn about patients and health stakeholder s behavior and in turn to deliver behavior-change content.
As part of the deal, Amalgam Rx will gain the company s psychosocial engine which is able to use data and AI to gain insights into personality, moods and motivators of individuals in 40 languages. The idea is that through these insights, more personalized content can be delivered to the end user, and the content can be responsive to the individual s needs.
25
DBMR has added a new report titled Clinical IT Market with analysis provides the insights which bring marketplace clearly into the focus and thus help organizations make better decisions. In this credible report, a study about market overview is performed by considering market drivers, market restraints, opportunities and challenges. Moreover, this report contains significant data, current market trends, market environment, technological innovation, upcoming technologies and the technical progress in the allied industry. This is the most relatable, exclusive, and commendable market research report formulated by focusing on definite business needs. The competitive analysis conducted in this report covers strategic profiling of key market players, their core competencies, and competitive landscape. To gain meaningful market insights and thrive in this competitive market place, this
What You Should Know: - Digital health company Sharecare and special purpose acquisition company (SPAC), Falcon Capital Acquisition Corp, today announced an agreement to merge to go public on the NASDAQ under the ticker symbol SHCR at enterprise value of $3.9B. - The transaction is expected to be funded through a combination of Falcon s $345 million of cash in trust (assuming no redemptions) supported by a $425 million fully committed PIPE at $10.00 per share and the Anthem
H|T: The Healthtech Times H|T: The Healthtech Times – Blunder drug
The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using the form at the bottom of this page to ensure you don’t miss out on the most important healthtech news every week!
RECOMMENDED BY HOCKEYSTICK:
“At Hustle Fund, we’re convinced that Canada is positioned well to produce some of the largest, category-defining companies on the planet. We’re eager to fund these companies, and excited to partner with Hockeystick to identify these opportunities!” – Eric Bahn (General Partner)
MedCity News
Read about news from Turing, ChromaCode, NeuroFlow and more.
Shares0
ChromaCode has been named a finalist in the XPRIZE Rapid Covid Testing Competition, which aims to increase testing capabilities & accelerate the development of high-quality testing that is low cost, easy to use & quick reporting.
Turing is pleased to announce that it is expanding its Board of Directors, adding Ashu Garg, General Partner at Foundation Capital, and Sumir Chadha, Co-founder and Managing Director at WestBridge Capital. The move comes after Turing’s recent announcement of its $32 million Series B funding round led by WestBridge Capital, which has a $3.3 billion fund, and including Foundation Capital, which led Turing’s earlier round. To date, Turing has raised nearly $50 million in venture funding.